Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.

“We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the Phase 3 SOTERIA open-label ...

Navigating the complexities of U.S. immigration can be daunting, especially for entry-level workers seeking to establish ...

“FDA clearance to advance Fertilo into a Phase 3 trial is a significant milestone for Gameto, and a landmark moment in iPSC technology,” said Dr. Dina Radenkovic, CEO and Co-Founder, Gameto.

JERUSALEM (AP) — Israeli Prime Minister Benjamin Netanyahu on Tuesday threatened to withdraw from the ceasefire in Gaza and ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American ... Segal Trials in furtherance of Cybin’s multinational pivotal Phase 3 program evaluating CYB003 for the adjunctive treatment of Major ...

Abstract: The steer-by-wire (SbW) system is regarded as the optimal steering solution for achieving ... To achieve exact, rapid, and robust tracking, this study utilizes a dual three-phase permanent ...

Bayern Munich claimed a 2-1 win away at Celtic on Wednesday to take the advantage in the match-up in the Champions League ...